- Home
- VTRS vs EPAM Comparison
VTRS vs EPAM Comparison
Compare VTRS & EPAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTRS
- EPAM
- Stock Information
- Founded
- VTRS 1961
- EPAM 1993
- Country
- VTRS United States
- EPAM United States
- Employees
- VTRS N/A
- EPAM N/A
- Industry
- VTRS Medicinal Chemicals and Botanical Products
- EPAM EDP Services
- Sector
- VTRS Health Care
- EPAM Technology
- Exchange
- VTRS Nasdaq
- EPAM Nasdaq
- Market Cap
- VTRS 9.0B
- EPAM 8.2B
- IPO Year
- VTRS N/A
- EPAM 2012
- Fundamental
- Price
- VTRS $8.77
- EPAM $176.98
- Analyst Decision
- VTRS Hold
- EPAM Buy
- Analyst Count
- VTRS 4
- EPAM 17
- Target Price
- VTRS $10.50
- EPAM $226.44
- AVG Volume (30 Days)
- VTRS 13.8M
- EPAM 704.2K
- Earning Date
- VTRS 05-08-2025
- EPAM 05-08-2025
- Dividend Yield
- VTRS 5.47%
- EPAM N/A
- EPS Growth
- VTRS N/A
- EPAM N/A
- EPS
- VTRS N/A
- EPAM 7.15
- Revenue
- VTRS $14,330,200,000.00
- EPAM $4,864,167,000.00
- Revenue This Year
- VTRS N/A
- EPAM $13.81
- Revenue Next Year
- VTRS $1.20
- EPAM $8.44
- P/E Ratio
- VTRS N/A
- EPAM $24.76
- Revenue Growth
- VTRS N/A
- EPAM 4.72
- 52 Week Low
- VTRS $6.85
- EPAM $138.15
- 52 Week High
- VTRS $13.55
- EPAM $269.00
- Technical
- Relative Strength Index (RSI)
- VTRS 57.48
- EPAM 63.22
- Support Level
- VTRS $8.47
- EPAM $156.21
- Resistance Level
- VTRS $9.57
- EPAM $185.61
- Average True Range (ATR)
- VTRS 0.30
- EPAM 4.78
- MACD
- VTRS 0.15
- EPAM 3.88
- Stochastic Oscillator
- VTRS 59.39
- EPAM 78.72
About VTRS Viatris Inc.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
About EPAM EPAM Systems Inc.
EPAM Systems is a global IT services firm that offers platform engineering, software development, and consulting services. EPAM's largest market is North America, which represents approximately 60% of revenue. Offerings span assisting companies with new technologies, such as artificial intelligence, virtual reality, and robotics.